A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

United States

UCLA, Los Angeles, California

Ochsner MD Anderson Cancer Center, New Orleans, Louisiana

START Midwest, Grand Rapids, Michigan

West Penn Allegheny Health, Pittsburgh, Pennsylvania

Mays Clinic, Houston, Texas

START San Antonio, San Antonio, Texas

Wisconsin Institute Medical Research- UW Cancer Connect, Madison, Wisconsin

Canada

Princess Margaret Cancer Center, Toronto, Ontario

McGill University, Montreal, Quebec

South Korea

National Cancer Center, Goyang-si, Gyeonggi-do

Seoul National University Hospital Bundang Hospital, Seongnam-si, Gyeonnggi-Do

Yonsei University Health System Severance Hospital, Seoul

Gangnam Severance Hospital, Seoul

Korea University Guro Hospital, Seoul

Seoul National University Hospital, Seoul

Samsung Medical Center, Seoul